Literature DB >> 9278892

Stability of curcumin in buffer solutions and characterization of its degradation products.

Y J Wang1, M H Pan, A L Cheng, L I Lin, Y S Ho, C Y Hsieh, J K Lin.   

Abstract

The degradation kinetics of curcumin under various pH conditions and the stability of curcumin in physiological matrices were investigated. When curcumin was incubated in 0.1 M phosphate buffer and serum-free medium, pH 7.2 at 37 degrees C, about 90% decomposed within 30 min. A series of pH conditions ranging from 3 to 10 were tested and the result showed that decomposition was pH-dependent and occurred faster at neutral-basic conditions. It is more stable in cell culture medium containing 10% fetal calf serum and in human blood; less than 20% of curcumin decomposed within 1 h, and after incubation for 8 h, about 50% of curcumin is still remained. Trans-6-(4'-hydroxy-3'-methoxyphenyl)-2,4-dioxo-5-hexenal was predicted as major degradation product and vanillin, ferulic acid, feruloyl methane were identified as minor degradation products. The amount of vanillin increased with incubation time.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278892     DOI: 10.1016/s0731-7085(96)02024-9

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  232 in total

1.  Curcumin regulates airway epithelial cell cytokine responses to the pollutant cadmium.

Authors:  Jessica Rennolds; Smitha Malireddy; Fatemat Hassan; Susheela Tridandapani; Narasimham Parinandi; Prosper N Boyaka; Estelle Cormet-Boyaka
Journal:  Biochem Biophys Res Commun       Date:  2011-11-28       Impact factor: 3.575

2.  Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: Similar root but different effects.

Authors:  Robert C G Martin; Harini S Aiyer; Daniel Malik; Yan Li
Journal:  Food Chem Toxicol       Date:  2011-11-04       Impact factor: 6.023

3.  Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin.

Authors:  Markus Griesser; Valentina Pistis; Takashi Suzuki; Noemi Tejera; Derek A Pratt; Claus Schneider
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

4.  Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

Authors:  Wing-Hin Lee; Ching-Yee Loo; Mary Bebawy; Frederick Luk; Rebecca S Mason; Ramin Rohanizadeh
Journal:  Curr Neuropharmacol       Date:  2013-07       Impact factor: 7.363

5.  Design and synthesis of novel iminothiazinylbutadienols and divinylpyrimidinethiones as ARE inducers.

Authors:  Lin Chen; Sadagopan Magesh; Hong Wang; Chung S Yang; Ah-Ng Tony Kong; Longqin Hu
Journal:  Bioorg Med Chem Lett       Date:  2013-12-24       Impact factor: 2.823

6.  Effects of hexahydrocurcumin in combination with 5-fluorouracil on dimethylhydrazine-induced colon cancer in rats.

Authors:  Khanitta Srimuangwong; Chainarong Tocharus; Jiraporn Tocharus; Apichart Suksamrarn; Pornphorm Yoysungnoen Chintana
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

7.  Active curcumin nanoparticles formed from a volatile microemulsion template.

Authors:  K Margulis; S Srinivasan; M J Ware; H D Summers; B Godin; S Magdassi
Journal:  J Mater Chem B       Date:  2014       Impact factor: 6.331

8.  Oxidative metabolites of curcumin poison human type II topoisomerases.

Authors:  Adam C Ketron; Odaine N Gordon; Claus Schneider; Neil Osheroff
Journal:  Biochemistry       Date:  2012-12-26       Impact factor: 3.162

9.  Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells.

Authors:  Xingchuan Wei; Zhi-Yun DU; Xiao-Xing Cui; Michael Verano; Rong Qing Mo; Zhi Kai Tang; Allan H Conney; Xi Zheng; Kun Zhang
Journal:  Oncol Lett       Date:  2012-05-10       Impact factor: 2.967

10.  Polymeric curcumin nanoparticle pharmacokinetics and metabolism in bile duct cannulated rats.

Authors:  Peng Zou; Lawrence Helson; Anirban Maitra; Stephan T Stern; Scott E McNeil
Journal:  Mol Pharm       Date:  2013-04-22       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.